Women with an HbA1c of 41–49 mmol/mol (5.9–6.6%): a higher risk subgroup that may benefit from early pregnancy intervention
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Aims: To examine whether women with an HbA 1c of 41–49 mmol/mol (5.9–6.6%) at diagnosis of gestational diabetes are higher risk than women with an HbA 1c of < 41 mmol/mol (5.9%) and whether pregnancy outcomes are improved if treated at < 24 weeks' gestation. Methods: This was an observational study of women with gestational diabetes diagnosed by early HbA 1c screening or subsequent oral glucose tolerance test at < 34 weeks' gestation who delivered at National Women's Health, Auckland, from July 2012 to June 2014. Data were extracted from the hospital database. Women with HbA 1c 41–49 mmol/mol (5.9–6.6%) were divided into those seen < 24 weeks (Early, n = 134) and those seen ≥ 24 weeks (Later, n = 151). Those with HbA 1c < 41 mmol/mol (5.9%) were labelled Other GDM (n = 661). Results: The Early and Later groups, compared with Other GDM, had more Polynesian and fewer (non‐Indian) Asian women, higher BMI and more required medication (P < 0.001). More were smokers (P = 0.007, 0.02) and more had chronic hypertension (P < 0.001, 0.02). There were higher rates of adverse outcomes in the Later group than the Other GDM group (pre‐eclampsia 8.0% vs. 2.4%, P = 0.001, preterm birth 16.6% vs. 8.2%, P = 0.002, neonatal admission 15.5% vs. 9.2%, P = 0.02). Outcomes were similar between the Early group and Other GDM group (pre‐eclampsia 1.5% vs. 2.4%, P = 0.5, preterm birth 10.5% vs. 8.2% P = 0.4, neonatal admission 13.6% vs. 9.2%, P = 0.12). Comparing the Early and Later groups, the Early group had less pre‐eclampsia, 1.5% vs. 8.0%, adjusted P = 0.03. Other outcomes were not statistically different. Conclusions: An HbA 1c of 41–49 mmol/mol (5.9–6.7%) identifies a higher‐risk group of women with gestational diabetes. Overall, our data support early treatment of women with an HbA 1c ≥ 41 mmol/mol (5.9%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Hughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
Self-citationHolmes, V. A., Young, I. S., Patterson, C. C., Pearson, D. W. M., Walker, J. D., Maresh, M. J. A., McCance, D. R., & for the Diabetes and Pre-eclampsia Intervention Trial Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0244 · Cited by 205
Glycemia and Its Relationship to Outcomes in the Metformin in Gestational Diabetes Trial
Rowan, J. A., Gao, W., Hague, W. M., & McIntyre, H. D. (2010) · Diabetes Care · doi:10.2337/dc09-1407 · Cited by 96
Self-citationDiffering causes of pregnancy loss in type 1 and type 2 diabetes
Cundy, T., Gamble, G., Neale, L., Elder, R., McPherson, P., Henley, P., & Rowan, J. (2007) · Diabetes Care · doi:10.2337/dc07-0555 · Cited by 90
Self-citation
Cited by
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Daly, B., Toulis, K. A., Thomas, N., Gokhale, K., Martin, J., Webber, J., Keerthy, D., Jolly, K., Saravanan, P., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002488 · Cited by 328
Immanuel, J., & Simmons, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0943-7 · Cited by 264
Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
Yang, Y., & Wu, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831297 · Cited by 155
“However, for the high-risk population with GDM, early screening and active treatment may reduce the risk of PE (85, 86).”
BackgroundRole of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort.
Mañé, L., Flores-Le Roux, J. A., Benaiges, D., Rodríguez, M., Marcelo, I., Chillarón, J. J., Pedro-Botet, J., Llauradó, G., Gortazar, L., Carreras, R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2581 · Cited by 91
“(11), who suggested that treating these women before 20 to 24 weeks of gestation may improve outcomes with reported lower rates of preeclampsia.”
Background
Metadata
- Authors
- Rowan, J. A., Budden, A., Ivanova, V., Hughes, R. C., & Sadler, L. C.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2015-06-15
- Volume
- 33
- Issue
- 1
- Pages
- 25-31
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1788990079
- Cited by
- 41
- References
- 6
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.